Agenda
21st WCIRDC AGENDA
Thursday, December 7, 2023
7:00 am Pre-Registration
7:00 am – 8:00 am Exhibit Hall Opens | Continental Breakfast
8:00 am – 8:15 am Welcome & Introduction | Pre-CME Questions Yehuda Handelsman, MD
​
Session 1 Endothelium and Cardiometabolic Disorders
8:15 am – 9:30 am Chairs: Vivian Fonseca * Derek LeRoith, MD
8:15 am The Effects of RYGB on Cholesterol and Bile Acid Metabolism in Humans Bart Staels, PhD
8:35 am Endothelial-Mesenchymal Transition in Cardiovascular Disease (EndMT) Jorge Plutzky, MD
8:55 am The Role of SGLTx in ACS, A. Fib & Metabolism- A Translational Approach Robert J. Chilton, DO
9:15 am – 9:30 am Panel Discussion and Q&A
Session 2 ASCVD Epidemiology, Pathophysiology & Management
9:30 am – 10:45 am Chairs: Ron Krauss, MD * Robert Chilton, MD
9:30 am Importance of Cardiovascular Risk Assessment and Multiple Risk Factor Control in Diabetes Nathan D. Wong, PhD
9:50 am Common Molecular Mechanisms Drive Cardiometabolic and Vascular Diseases Outcomes- Clinical Implications W. Timothy Garvey, MD
10:10 am The Relationships Between HDL Dysfunction, Genetic Very Small LDL, CAC and Insulin Resistance Arthur S. Agatston, MD
10:30 am – 10:45 am Panel Discussion and Q&A
10:45 am – 11:15 am REFRESHMENT BREAK at the Exhibit Hall
Session 3 Lipidology Toward 2024- Panel Discussion
11:15 am – 12:10 pm Chairs: Erin Michos, MD * Chris Guerin, MD
11:15 am The Role of the Mitochondrial/ER Axis in Cholesterol Metabolism and Statin Myopathy Ronald M. Krauss, MD
Lpa, CETP / BA-CLEAR / Very High HDL Seth S. Martin, MD, MHS
Discussions and Q&A Panelist
12:10 pm
Session 4 Concurrent Sessions: Meet the Experts
12:15 pm – 1:00 pm 45 mins
Ralph A. DeFronzo, MD Insulin Resistance – Intensive Management of DM Sierra C/D (Lecture Hall)
Vivian A. Fonseca, MD DCRM Risk Prediction Club
Jennifer Green, MD CKD Emerging Strategies Hiro
Yehuda Handelsman, MD Technology in DM and CRM Salon 6AB
1:00 pm – 2:00 pm LUNCH BREAK
1:10 pm – 1:55 pm Lunch Session Non-CME Product Theater Hall
Lecture Title Speaker
Supported by BI/Lilly
Session 5 Metabolic Science
2:00 pm – 2:50 pm Chairs: Richard Bergman, PhD * Phillip Scherer, PhD
2:00 pm Genome- Proteome- Phenome & Mendelian Randomization Studies, Elucidating Novel Pathways and Treatments-
Clinical Implication in Cardiometabolic Disorders Christos S. Mantzoros, MD, PhD
2:20 pm The Role of mRNA Modifications in the Regulation of Metabolism Rohit Kulkarni, MD, PhD
2:40 pm – 2:50 pm Panel Discussion and Q&A
​
Session 6 The Future of HTN
2:50 pm – 3:40 pm Chairs: Pam Taub, MD * Chris Mende, MD
2:50 pm Need for New agents to Overcome Healthcare Disparity in Hypertension Keith Ferdinand, MD
3:10 pm Refractory HTN and New Drugs & Procedures in the Future Norman Lepor, MD
3:30 pm – 3:40 pm Panel Discussion and Q&A
Session 7 DCRM 2.0 – Update and Global Transformation
3:40pm – 4:10 pm Chairs: Richard Pratley, MD * Matt Weir MD
3:40 am DCRM 2.0 - Diabetes CardioRenal & Metabolic Diseases- Update & Global Yehuda Handelsman, MD
3:55 pm – 4:10 pm Panel Discussion and Q&A
4:10 pm – 4:40 pm REFRESHMENT BREAK at the Exhibit Hall
Session 8 Insulin Resistance, Diabetes, and Beyond
5:00 pm – 6:30 pm Chairs: Jennifer Green, MD *Jorge Plutzky, MD
4:40 pm Brain HDL and Alzheimer’s Disease: Toward Therapeutic Applications Hussein Yassine, MD
5:00 pm Pulmonary Disease in Diabetes- Another Final Frontier? Peter J. Grant, MD
5:20 pm Contemporary Nomenclature of Fatty Liver Disease Impact on Diagnosis and Management Rohit Loomba, MD, MHSc
5:40 pm Vascular Aging in CKD Matthew R. Weir, MD
6:00pm Management of Diabetes in Patients with Cancer Addressing Impact of Cancer Therapy
Overcoming Treatment Challenges: Management of Patients with Diabetes and Cancer
Emily J Gallagher, MD, PhD
6:20 pm – 6:35 pm Panel Discussion and Q&A
6:35pm – 7:30 pm WELCOME & POSTER RECEPTION AT EXHIBIT HALL
7:30 pm – 9:15 pm Dinner CME Symposium Supported by TBD
Winning The Trifecta of Diabetes, the Heart and Kidney diseases
Chairs: Yehuda Handelsman, MD • Muthu Vaduganathan, MD
7:30 pm Introduction & Pre-CME Questions Muthu Vaduganathan, MD, MPH
7:50 pm Early intervention in Diabetes addressing pathophysiology in preventing comorbidities Vivian A. Fonseca , MD
8:10 pm SGLT2i effects across the spectrum of CKD and multiple Populations Peter Rossing, MD
8:30 pm Impact of SGLT2i on HF Outcomes in Various Populations & the range of LVEF Muthu Vaduganathan, MD, MPH
8:50 pm Panel Discussion and Q&A: Changing the Trajectory of Heart Failure and CKD, Implementing Guidelines Directed Medical Therapy
Panel: Vivian A. Fonseca, MD, Christian W. Mende, MD, Erin D. Michos, MD, MHS, Peter Rossing, MD,
Muthu Vaduganathan, MD,
Moderator: Yehuda Handelsman, MD
9:10 pm Concluding Remarks & Post-CME Questions
9:15 pm Adjourn